Cargando…

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis

Anti‐diabetic agent‐related hypoglycemia is a serious complication in type 2 diabetic patients on hemodialysis. Therefore, we assessed the efficacy and tolerability of 24 weeks of monotherapy with vildagliptin, a dipeptidyl peptidase four inhibitor, which is a new class of antidiabetic agent. This o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kume, Shinji, Uzu, Takashi, Takagi, Chieko, Kondo, Morihiro, Okabe, Tomoko, Araki, Shin‐ichi, Isshiki, Keiji, Takeda, Naoko, Kondo, Keiko, Haneda, Masakazu, Koya, Daisuke, Nishio, Yoshihiko, Kashiwagi, Atsunori, Maegawa, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014953/ https://www.ncbi.nlm.nih.gov/pubmed/24843580 http://dx.doi.org/10.1111/j.2040-1124.2011.00169.x

Ejemplares similares

Association Between Urinary Type IV Collagen Level and Deterioration of Renal Function in Type 2 Diabetic Patients Without Overt Proteinuria
por: Araki, Shin-ichi, et al.
Publicado: (2010)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Arterial stiffness and renal impairment in non‐proteinuric type 2 diabetic patients
por: Nakao, Keiko, et al.
Publicado: (2011)

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
por: Yang, Xu, et al.
Publicado: (2011)

Cilostazol Attenuates Spontaneous Microaggregation of Platelets in Type 2 Diabetic Patients With Insufficient Platelet Response to Aspirin
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Secular changes in clinical manifestations of kidney disease among Japanese adults with type 2 diabetes from 1996 to 2014
por: Kume, Shinji, et al.
Publicado: (2019)

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2016)

Predictive Properties of Plasma Amino Acid Profile for Cardiovascular Disease in Patients with Type 2 Diabetes
por: Kume, Shinji, et al.
Publicado: (2014)

Correlation Between Albuminuria and Spontaneous Platelet Microaggregate Formation in Type 2 Diabetic Patients
por: Araki, Shin-ichi, et al.
Publicado: (2009)

Oral glucose‐stimulated serum C‐peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairment
por: Araki, Hisazumi, et al.
Publicado: (2013)

Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy
por: Araki, Hisazumi, et al.
Publicado: (2013)

Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus
por: Sawaguchi, Makoto, et al.
Publicado: (2012)

Peroxisome Proliferator-Activated Receptors in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2008)

Effects of blood pressure and the renin‐angiotensin system on platelet activation in type 2 diabetes
por: Uzu, Takashi, et al.
Publicado: (2010)

Mammalian autophagy is essential for hepatic and renal ketogenesis during starvation
por: Takagi, Ayano, et al.
Publicado: (2016)

Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2014)

The Role of Autophagy in the Pathogenesis of Diabetic Nephropathy
por: Yamahara, Kosuke, et al.
Publicado: (2013)

Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells
por: Iwai, Tamaki, et al.
Publicado: (2016)

Autophagy as a Therapeutic Target in Diabetic Nephropathy
por: Tanaka, Yuki, et al.
Publicado: (2012)

4-Hydroxy Hexenal Derived from Docosahexaenoic Acid Protects Endothelial Cells via Nrf2 Activation
por: Ishikado, Atsushi, et al.
Publicado: (2013)

Sodium–glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients
por: Kashiwagi, Atsunori, et al.
Publicado: (2020)

Association between single nucleotide polymorphisms within genes encoding sirtuin families and diabetic nephropathy in Japanese subjects with type 2 diabetes
por: Maeda, Shiro, et al.
Publicado: (2011)

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
por: Uzu, Takashi, et al.
Publicado: (2016)

Therapeutic management of diabetic kidney disease
por: Koya, Daisuke, et al.
Publicado: (2011)

Impact of obesity on annual medical expenditures and diabetes care in Japanese patients with type 2 diabetes mellitus
por: Kusunoki‐Tsuji, Chisato, et al.
Publicado: (2017)

Role of dietary amino acid balance in diet restriction‐mediated lifespan extension, renoprotection, and muscle weakness in aged mice
por: Yoshida, Shohei, et al.
Publicado: (2018)

Metabolic and hemodynamic effects of sodium‐dependent glucose cotransporter 2 inhibitors on cardio‐renal protection in the treatment of patients with type 2 diabetes mellitus
por: Kashiwagi, Atsunori, et al.
Publicado: (2017)

Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes
por: Miyagawa, Katsutoshi, et al.
Publicado: (2013)

Evaluation of a Novel Glucose Area Under the Curve (AUC) Monitoring System: Comparison with the AUC by Continuous Glucose Monitoring
por: Ugi, Satoshi, et al.
Publicado: (2016)

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
por: Seino, Yutaka, et al.
Publicado: (2010)

A dialysis patient with hyperammonaemia: inferior mesenteric-caval shunt as a cause of portal-systemic encephalopathy
por: Izumiya-Iwai, Tamaki, et al.
Publicado: (2011)

A case of vildagliptin-induced interstitial pneumonia
por: Kuse, Naoyuki, et al.
Publicado: (2016)

New glycemic targets for patients with diabetes from the Japan Diabetes Society
por: Araki, Eiichi, et al.
Publicado: (2016)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Lipotoxicity, Nutrient-Sensing Signals, and Autophagy in Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2020)

A new era of diabetic kidney disease treatment with sodium–glucose cotransporter‐2 inhibitors
por: Kume, Shinji, et al.
Publicado: (2022)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Successful Renal Replacement Therapy for a Patient with Severe Hemophilia after Surgical Treatment of Intracranial Hemorrhage and Hydrocephalus
por: Kato, Noriko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_h1pujnl5p36pfbkkhhu2t4qh62